Video

Dr. Baron on Contributing Factors for Developing Breast Cancer

Paul Lawrence Baron, MD, discusses contributing factors for developing breast cancer.

Paul Lawrence Baron, MD, chief, Breast Surgery, director, Breast Cancer Program, Lenox Hill Hospital, Northwell Health, discusses contributing factors for developing breast cancer.

Individuals who are at a high risk of developing breast cancer include those who have inherited genes, such as BRCA1 or BRCA2, which increase their risk of breast cancer, Baron explains. Additionally, people with a family history of breast cancer who do not have confirmed genetic mutations have a heightened risk as well. 

Other characteristics of individuals with a high risk of developing breast cancer include those with a previous history of radiation to their chest, those in which a prior biopsy revealed atypical hyperplasia or lobular carcinoma in situ, or those with dense breast tissue, Baron says.

Ultimately, all patients with a high risk of developing breast cancer require close monitoring to identify breast cancer early, Baron concludes.

Newsletter

Stay up to date on the most recent and practice-changing oncology data

Latest CME

View All
Community Practice Connections™: Empowering Interventional Radiologists in the Emerging Era of Oncolytic Immunotherapies for Melanoma
Multimedia

Community Practice Connections™: Empowering Interventional Radiologists in the Emerging Era of Oncolytic Immunotherapies for Melanoma

May 15th 2025 - May 16th 2026

online-activity
Show Me Your Care Plan!™ Insights for Oncology Nurses: Integrating Recent Developments to Improve Outcomes for Patients With Platinum-Resistant Ovarian Cancer
Video

Show Me Your Care Plan!™ Insights for Oncology Nurses: Integrating Recent Developments to Improve Outcomes for Patients With Platinum-Resistant Ovarian Cancer

May 15th 2025 - May 16th 2026

online-activity
Community Oncology Connections™: Community Oncologists’ Role in Selecting Optimal Oral SERD Treatment for HR+/HER2– Breast Cancer | Louisiana
Video

Community Oncology Connections™: Community Oncologists’ Role in Selecting Optimal Oral SERD Treatment for HR+/HER2– Breast Cancer | Louisiana

May 14th 2025 - Jun 19th 2025

online-activity